Search research articles
Contact Us
Filters
Showing results (701-710 of 776) with videos related to
Page
of 78
Sort By:
The Journal of Experimental Medicine
|
April 5, 2012
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease
Lin W Hung, Victor L Villemagne, Lesley Cheng, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
September 26, 2021
Deep Generative Medical Image Harmonization for Improving Cross-Site Generalization in Deep Learning Predictors
Vishnu M Bashyam, Jimit Doshi, Guray Erus, et al.
The Lancet. Neurology
|
October 26, 2016
Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)
Mengxuan Tang, Davis C Ryman, Eric McDade, et al.
The New England Journal of Medicine
|
July 13, 2012
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Randall J Bateman, Chengjie Xiong, Tammie L S Benzinger, et al.
Nature Communications
|
March 20, 2025
Machine learning reveals distinct neuroanatomical signatures of cardiovascular and metabolic diseases in cognitively unimpaired individuals
Sindhuja Tirumalai Govindarajan, Elizabeth Mamourian, Guray Erus, et al.
Journal of Alzheimer'S Disease : JAD
|
April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging
James K Lui, Simon M Laws, Qiao-Xin Li, et al.
Brain : a Journal of Neurology
|
June 28, 2020
MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide
Vishnu M Bashyam, Guray Erus, Jimit Doshi, et al.
Brain : a Journal of Neurology
|
March 10, 2018
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing
Jasmeer P Chhatwal, Aaron P Schultz, Keith A Johnson, et al.
Nature Communications
|
January 29, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
Katharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 11, 2026
AI-enhanced Centiloid quantification of amyloid PET images
Pierrick Bourgeat, Jurgen Fripp, Leo Lebrat, et al.
Page
of 78
Search research articles
Search
Showing results (701-710 of 776) with videos related to
Sort By:
Page
of 78
The Journal of Experimental Medicine
|
April 5, 2012
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease
Lin W Hung, Victor L Villemagne, Lesley Cheng, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
September 26, 2021
Deep Generative Medical Image Harmonization for Improving Cross-Site Generalization in Deep Learning Predictors
Vishnu M Bashyam, Jimit Doshi, Guray Erus, et al.
The Lancet. Neurology
|
October 26, 2016
Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)
Mengxuan Tang, Davis C Ryman, Eric McDade, et al.
The New England Journal of Medicine
|
July 13, 2012
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Randall J Bateman, Chengjie Xiong, Tammie L S Benzinger, et al.
Nature Communications
|
March 20, 2025
Machine learning reveals distinct neuroanatomical signatures of cardiovascular and metabolic diseases in cognitively unimpaired individuals
Sindhuja Tirumalai Govindarajan, Elizabeth Mamourian, Guray Erus, et al.
Journal of Alzheimer'S Disease : JAD
|
April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging
James K Lui, Simon M Laws, Qiao-Xin Li, et al.
Brain : a Journal of Neurology
|
June 28, 2020
MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide
Vishnu M Bashyam, Guray Erus, Jimit Doshi, et al.
Brain : a Journal of Neurology
|
March 10, 2018
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing
Jasmeer P Chhatwal, Aaron P Schultz, Keith A Johnson, et al.
Nature Communications
|
January 29, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
Katharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 11, 2026
AI-enhanced Centiloid quantification of amyloid PET images
Pierrick Bourgeat, Jurgen Fripp, Leo Lebrat, et al.
Page
of 78